Enterprise record

Inmune Bio, Inc. logo

Inmune Bio, Inc.

Public governance Claims and source records for this enterprise.

Follow
More
Reports & analysis (Directory temporarily unavailable)Alpha EvalSave PDFCompareChallenge a ClaimClaim this record

Alpha ID: alpha:company:a0f62a80-958f-46ca-b155-b220e0af379fVersion: public-1As of: unavailable

11 published Claims3 sources

Key Claims

Board and committees

Source-backed public-market identity

Index memberships

Current memberships are attached to a specific security and listing. Announcements, effective dates, and removals remain distinct states; Alpha does not infer membership from company size, exchange, or reputation.

No current membership is published in Alpha's tracked index universe.

This is not evidence that the company is absent from every market index.

As of Sep 30, 2026. Rights-filtered public evidence only; no redistribution or model training is granted.

Only source-backed memberships with an explicit public redistribution basis are returned.

Evidence, history and coverage

Additional published Claims

Published evidence records

3 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. Alpha canonical company public projection

    canonical identity · Source published: Date unavailable · Retrieved: Sep 29, 2026

    Supports 3 claims
    • Legal Name: Inmune Bio, Inc. · Claim reviewed: Sep 29, 2026
    • Entity Status: Public listing published · Claim reviewed: Sep 29, 2026
    • Published Fact: US · Claim reviewed: Sep 29, 2026

  2. Inmune Bio, Inc. DEF 14A 2026-04-23

    sec proxy · Source published: Apr 23, 2026 · Retrieved: Apr 24, 2026

    Supports 5 claims
    • Leadership Role: David J. Moss: Director · Claim reviewed: Sep 29, 2026
    • Leadership Role: J. Kelly Ganjei: Director · Claim reviewed: Sep 29, 2026
    • Leadership Role: Marcia Allen: Director · Claim reviewed: Sep 29, 2026
    • Leadership Role: Scott Juda, J.D.: Director · Claim reviewed: Sep 29, 2026
    • Leadership Role: Timothy Schroeder: Director · Claim reviewed: Sep 29, 2026

  3. INMB DEF 14A executive officers

    sec filing · Source published: Apr 23, 2026 · Retrieved: May 16, 2026

    Supports 3 claims
    • Leadership Role: Cory Ellspermann: Chief Financial Officer · Claim reviewed: Sep 29, 2026
    • Leadership Role: David J. Moss: President, CEO, Secretary, Treasurer and Director · Claim reviewed: Sep 29, 2026
    • Leadership Role: Mark Lowdell, PhD: Chief Scientific Officer · Claim reviewed: Sep 29, 2026